Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy (Q51048190)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 September 2014

Language	Label	Description	Also known as
English	Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy	scientific article published on 30 September 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

author name string

Chien-Feng Li

1

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Hong-Lin He

2

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Jaw-Yuan Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Hsuan-Ying Huang

4

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Ting-Fe Wu

5

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Chung-Hsi Hsing

6

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Sung-Wei Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Hao-Hsien Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Jui-Lung Fang

9

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Wen-Tsung Huang

10

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Shang-Hung Chen

11

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

language of work or name

0 references

publication date

30 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

67

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

12

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

1056-1061

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Fibroblast growth factor signalling: from development to cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Cellular signaling by fibroblast growth factor receptors

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

A novel angiogenesis inhibitor, Ki23057, is useful for preventing the progression of colon cancer and the spreading of cancer cells to the liver

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

TSU68, an antiangiogenic receptor tyrosine kinase inhibitor, induces tumor vascular normalization in a human cancer xenograft nude mouse model

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Assessment of the in vivo antitumor effects of ENMD-2076, a novel multitargeted kinase inhibitor, against primary and cell line-derived human colorectal cancer xenograft models

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Fibroblast growth factor receptor 2 IIIc as a therapeutic target for colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202551

21 January 2018

Identifiers

10.1136/JCLINPATH-2014-202551

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 March 2018

http://europepmc.org/abstract/MED/25271212

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51048190&oldid=2266554977"